Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?
The global supply chain for bovine and porcine heparin and regulatory considerations are examined.
Ali Al-Hakim
Advertisement
Ali Al-Hakim is acting director of Division of New Drug API at the FDA.
Articles by Ali Al-Hakim
Advertisement
Latest Updated Articles
Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?Published: November 2nd 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
3
Challenges for the Global Manufacturing of Vaccines
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
